Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-25 @ 2:32 AM
NCT ID:
NCT06277934
Brief Summary:
The main purpose of this study was to evaluate the safety and tolerability of RGT001-075 in healthy participants with obesity
Study:
NCT06277934
Study Brief:
Protocol Section:
NCT06277934